HeyJaredKatie Anderson
- Indexed articles, last 90 days
- 10
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Pharmaceuticalonline
- Top 5M sites
- Earliest in this view
- Jul 13, 2026
Latest articles
Why CMC Tech Transfer Should Begin With The End In Mind (opens the original)
Read excerpt
By Katie Anderson, Chief Editor, Pharmaceutical Online As pipelines become more differentiated, regulatory requirements more complex, competition more intense, and demand continues to rise, sponsors can easily become consumed by the immediate tasks of CMC technology transfer. Yet, the end goals must remain top of mind throughout the process. In part one of this interview, I spoke with Tuneer Ghosh, president of CMC at Sai Life Sciences, about how to build a successful technology transfer. In par
4 Ways To Building A Better CMC Tech Transfer (opens the original)
Read excerpt
By Katie Anderson, Chief Editor, Pharmaceutical Online A technology transfer can falter long before a process reaches the plant. Gaps in process knowledge, mismatched equipment, and insufficient scale-up data can all undermine reproducibility, timelines, and cost. For Tuneer Ghosh, president of CMC at Sai Life Sciences, reducing those risks starts with a shared technical understanding between the sponsor and its CDMO. In our conversation, Ghosh outlined four areas CMC teams should prioritize to
09.12.26 -- Pharmaceutical Online Newsletter - Best Of August (opens the original)
Read excerpt
Webinar: Future-Proofing Your USP Strategy: Preparing for the Next Generation of Biological Reactivity Testing Is your organization ready for the revised USP ? Join Pace® Life Sciences to explore anticipated changes to biological reactivity testing and what they could mean for material qualification, validation, and compliance. Gain practical insights into evolving regulatory expectations, testing readiness, and strategies to support a smooth transition ahead of the December 1, 2026 release. Cli
AI Governance Is Just Like Driving A Race Car (opens the original)
Read excerpt
By Katie Anderson, Chief Editor, Pharmaceutical Online Though some skeptics remain, nearly every business is at some stage of AI adoption. The technology has proven applications in pharmaceutical manufacturing, but effective governance must keep pace with its rapid development. That challenge is familiar to Bill Reid, healthcare and life sciences lead in Google’s Chief Information Security Office (CISO). At his presentation at ISPE’s AI in Life Sciences Conference, Reid explained the framework f
Can U.S. Policy Bring Generic Drug Manufacturing Back Home? (opens the original)
Read excerpt
By Katie Anderson, Chief Editor, Pharmaceutical Online The U.S. pharmaceutical industry is on the cusp of change, as large manufacturers pledge billions of dollars and break ground on domestic facilities to produce drug products and APIs. But will those investments strengthen the supply chain, and what will they mean for the generic medicines that account for 90% of prescriptions in the U.S.? Generic medicines imported into the U.S. were not subject to the recently imposed tariffs on imported ph
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Pharmaceuticalonline, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.